Literature DB >> 18812174

Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim.

Maria Dolores Herman1, Tomas Nyman, Martin Welin, Lari Lehtiö, Susanne Flodin, Lionel Trésaugues, Tetyana Kotenyova, Alex Flores, Pär Nordlund.   

Abstract

Evasion of apoptosis is recognized as a characteristic of malignant growth. Anti-apoptotic B-cell lymphoma-2 (Bcl-2) family members have therefore emerged as potential therapeutic targets due to their critical role in proliferating cancer cells. Here, we present the crystal structure of Bfl-1, the last anti-apoptotic Bcl-2 family member to be structurally characterized, in complex with a peptide corresponding to the BH3 region of the pro-apoptotic protein Bim. The structure reveals distinct features at the peptide-binding site, likely to define the binding specificity for pro-apoptotic proteins. Superposition of the Bfl-1:Bim complex with that of Mcl-1:Bim reveals a significant local plasticity of hydrophobic interactions contributed by the Bim peptide, likely to be the basis for the multi specificity of Bim for anti-apoptotic proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812174     DOI: 10.1016/j.febslet.2008.09.028

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  34 in total

Review 1.  BCL2A1: the underdog in the BCL2 family.

Authors:  M Vogler
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

2.  Structural and biochemical analysis of Bcl-2 interaction with the hepatitis B virus protein HBx.

Authors:  Tianyu Jiang; Minhao Liu; Jianping Wu; Yigong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

3.  Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes.

Authors:  Emiko Fire; Stefano V Gullá; Robert A Grant; Amy E Keating
Journal:  Protein Sci       Date:  2010-03       Impact factor: 6.725

4.  Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins.

Authors:  Glenna Wink Foight; Amy E Keating
Journal:  J Mol Biol       Date:  2015-05-23       Impact factor: 5.469

Review 5.  Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment.

Authors:  Cristina Correia; Sun-Hee Lee; X Wei Meng; Nicole D Vincelette; Katherine L B Knorr; Husheng Ding; Grzegorz S Nowakowski; Haiming Dai; Scott H Kaufmann
Journal:  Biochim Biophys Acta       Date:  2015-03-27

6.  Peptide design by optimization on a data-parameterized protein interaction landscape.

Authors:  Justin M Jenson; Vincent Xue; Lindsey Stretz; Tirtha Mandal; Lothar Luther Reich; Amy E Keating
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-15       Impact factor: 11.205

7.  A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers.

Authors:  James L LaBelle; Samuel G Katz; Gregory H Bird; Evripidis Gavathiotis; Michelle L Stewart; Chelsea Lawrence; Jill K Fisher; Marina Godes; Kenneth Pitter; Andrew L Kung; Loren D Walensky
Journal:  J Clin Invest       Date:  2012-05-24       Impact factor: 14.808

8.  Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway.

Authors:  M J Roy; A Vom; P E Czabotar; G Lessene
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

9.  Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL.

Authors:  Sanjib Dutta; Stefano Gullá; T Scott Chen; Emiko Fire; Robert A Grant; Amy E Keating
Journal:  J Mol Biol       Date:  2010-04-02       Impact factor: 5.469

10.  The C-terminal domain of A1/Bfl-1 regulates its anti-inflammatory function in human endothelial cells.

Authors:  Renata P Guedes; Eduardo Rocha; Jerome Mahiou; Herwig P Moll; Maria B Arvelo; Janis M Taube; Clayton R Peterson; Elzbieta Kaczmarek; Christopher R Longo; Cleide G da Silva; Christiane Ferran
Journal:  Biochim Biophys Acta       Date:  2013-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.